Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.
Journal: Journal for immunotherapy of cancer
Published: August 10, 2026
Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 29, 2025
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program.
Journal: Cancer cell
Published: September 18, 2025
Mutational and co-mutational landscape of early onset colorectal cancer.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: January 06, 2025
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted Alteration.
Journal: JCO precision oncology
Published: November 07, 2024
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials.
Journal: Cancer treatment reviews
Published: August 10, 2024
Interpretation of long-term overall survival from the PRODIGE 23 study. Letter to the Editor regarding 'Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial', by T. Conroy et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 28, 2024
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy.
Journal: Therapeutic advances in medical oncology
Published: July 02, 2024
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.
Journal: Therapeutic advances in medical oncology
Published: May 25, 2024
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 24, 2024
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset.
Journal: ESMO open
Published: February 15, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2023
Last Updated: 09/26/2026